Logo image of ECX

ECARX HOLDINGS INC-CL A (ECX) Stock Fundamental Analysis

NASDAQ:ECX - Nasdaq - KYG292011031 - Common Stock - Currency: USD

0.9041  -0.04 (-4.63%)

After market: 0.9065 +0 (+0.27%)

Fundamental Rating

1

ECX gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 81 industry peers in the Automobile Components industry. ECX has a bad profitability rating. Also its financial health evaluation is rather negative. ECX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ECX has reported negative net income.
In the past year ECX has reported a negative cash flow from operations.
In the past 5 years ECX always reported negative net income.
In the past 5 years ECX always reported negative operating cash flow.
ECX Yearly Net Income VS EBIT VS OCF VS FCFECX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -500M -1B -1.5B

1.2 Ratios

Looking at the Return On Assets, with a value of -22.03%, ECX is doing worse than 90.12% of the companies in the same industry.
Industry RankSector Rank
ROA -22.03%
ROE N/A
ROIC N/A
ROA(3y)-32.66%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ECX Yearly ROA, ROE, ROICECX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 200 -200 400 600 800

1.3 Margins

The Gross Margin of ECX (27.22%) is worse than 61.73% of its industry peers.
ECX's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for ECX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.42%
GM growth 5YN/A
ECX Yearly Profit, Operating, Gross MarginsECX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 20 -20 -40

More info and screens

0

2. Health

2.1 Basic Checks

ECX does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for ECX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ECX Yearly Shares OutstandingECX Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 100M 200M 300M
ECX Yearly Total Debt VS Total AssetsECX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 1B 2B 3B 4B

2.2 Solvency

ECX has an Altman-Z score of -1.78. This is a bad value and indicates that ECX is not financially healthy and even has some risk of bankruptcy.
ECX's Altman-Z score of -1.78 is on the low side compared to the rest of the industry. ECX is outperformed by 92.59% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.78
ROIC/WACCN/A
WACC7.32%
ECX Yearly LT Debt VS Equity VS FCFECX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 500M -500M -1B -1.5B

2.3 Liquidity

A Current Ratio of 0.78 indicates that ECX may have some problems paying its short term obligations.
ECX's Current ratio of 0.78 is on the low side compared to the rest of the industry. ECX is outperformed by 96.30% of its industry peers.
A Quick Ratio of 0.74 indicates that ECX may have some problems paying its short term obligations.
With a Quick ratio value of 0.74, ECX is not doing good in the industry: 87.65% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.78
Quick Ratio 0.74
ECX Yearly Current Assets VS Current LiabilitesECX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 1B 2B 3B 4B

More info and screens

3

3. Growth

3.1 Past

The earnings per share for ECX have decreased strongly by -648.51% in the last year.
EPS 1Y (TTM)-648.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%637.63%

3.2 Future

The Earnings Per Share is expected to grow by 36.75% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 19.57% on average over the next years. This is quite good.
EPS Next Y70.94%
EPS Next 2Y50.3%
EPS Next 3Y36.75%
EPS Next 5YN/A
Revenue Next Year29.93%
Revenue Next 2Y28.76%
Revenue Next 3Y26.84%
Revenue Next 5Y19.57%

3.3 Evolution

ECX Yearly Revenue VS EstimatesECX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B 10B
ECX Yearly EPS VS EstimatesECX Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 0 1 -1 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ECX. In the last year negative earnings were reported.
Also next year ECX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ECX Price Earnings VS Forward Price EarningsECX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ECX Per share dataECX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

A more expensive valuation may be justified as ECX's earnings are expected to grow with 36.75% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y50.3%
EPS Next 3Y36.75%

More info and screens

0

5. Dividend

5.1 Amount

ECX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ECARX HOLDINGS INC-CL A

NASDAQ:ECX (4/17/2025, 8:14:43 PM)

After market: 0.9065 +0 (+0.27%)

0.9041

-0.04 (-4.63%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)03-11 2025-03-11/bmo
Earnings (Next)N/A N/A
Inst Owners3.56%
Inst Owner Change0%
Ins Owners0.03%
Ins Owner Change0%
Market Cap335.18M
Analysts82.22
Price Target4.41 (387.78%)
Short Float %0.55%
Short Ratio0.25
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-6.2%
Min EPS beat(2)-21.01%
Max EPS beat(2)8.61%
EPS beat(4)3
Avg EPS beat(4)17%
Min EPS beat(4)-21.01%
Max EPS beat(4)43.42%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)7.86%
Min Revenue beat(2)-8.62%
Max Revenue beat(2)24.34%
Revenue beat(4)1
Avg Revenue beat(4)3.44%
Min Revenue beat(4)-8.62%
Max Revenue beat(4)24.34%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)18.74%
PT rev (3m)17.61%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-619.77%
EPS NY rev (1m)0%
EPS NY rev (3m)-13.64%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)619.79%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.82%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.52
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.39
EYN/A
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)-0.48
FCFYN/A
OCF(TTM)-0.46
OCFYN/A
SpS1.72
BVpS-0.34
TBVpS-0.41
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -22.03%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.22%
FCFM N/A
ROA(3y)-32.66%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.42%
GM growth 5YN/A
F-Score3
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 72.49%
Cap/Sales 1.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.78
Quick Ratio 0.74
Altman-Z -1.78
F-Score3
WACC7.32%
ROIC/WACCN/A
Cap/Depr(3y)127.55%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.59%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-648.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.33%
EPS Next Y70.94%
EPS Next 2Y50.3%
EPS Next 3Y36.75%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%637.63%
Revenue Next Year29.93%
Revenue Next 2Y28.76%
Revenue Next 3Y26.84%
Revenue Next 5Y19.57%
EBIT growth 1Y55.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year14.63%
EBIT Next 3Y36.15%
EBIT Next 5Y24.38%
FCF growth 1Y-144.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-206.41%
OCF growth 3YN/A
OCF growth 5YN/A